Literature DB >> 20613722

Approaches to simultaneous analysis of frequency and severity of symptoms.

E L Plan1, K E Karlsson, M O Karlsson.   

Abstract

Mesh：

Year:  2010        PMID： 20613722     DOI： 10.1038/clpt.2010.118

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  10 in total

1.  Performance of three estimation methods in repeated time-to-event modeling.

Authors:  Kristin E Karlsson; Elodie L Plan; Mats O Karlsson
Journal:  AAPS J       Date:  2011-01-13       Impact factor: 4.009

2.  A Pharmacokinetic-Pharmacodynamic Model of Morphine Exposure and Subsequent Morphine Consumption in Postoperative Pain.

Authors:  Rasmus Vestergaard Juul; Joakim Nyberg; Trine Meldgaard Lund; Sten Rasmussen; Mads Kreilgaard; Lona Louring Christrup; Ulrika S H Simonsson
Journal:  Pharm Res       Date:  2016-01-11       Impact factor: 4.200

3.  Pharmacodynamic Analysis of Morphine Time-to-Remedication Events in Infants and Young Children After Congenital Heart Surgery.

Authors:  Mohammed H Elkomy; David R Drover; Jeffery L Galinkin; Gregory B Hammer; Kristi L Glotzbach
Journal:  Clin Pharmacokinet       Date:  2016-10       Impact factor: 6.447

4.  Comparisons of Analysis Methods for Proof-of-Concept Trials.

Authors:  K E Karlsson; C Vong; M Bergstrand; E N Jonsson; M O Karlsson
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-01-16

5.  A time to event tutorial for pharmacometricians.

Authors:  Nick Holford
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-05-15

6.  Modeling and simulation of count data.

Authors:  E L Plan
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-08-13

7.  New generalized poisson mixture model for bimodal count data with drug effect: An application to rodent brief-access taste aversion experiments.

Authors:  Y Sheng; J Soto; M Orlu Gul; M Cortina-Borja; C Tuleu; J F Standing
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-07-29

8.  Analysis of Longitudinal-Ordered Categorical Data for Muscle Spasm Adverse Event of Vismodegib: Comparison Between Different Pharmacometric Models.

Authors:  Tong Lu; Yujie Yang; Jin Y Jin; Matts Kågedal
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-01-30

Review 9.  A survey of new oncology drug approvals in the USA from 2010 to 2015: a focus on optimal dose and related postmarketing activities.

Authors:  Dan Lu; Tong Lu; Mark Stroh; Richard A Graham; Priya Agarwal; Luna Musib; Chi-Chung Li; Bert L Lum; Amita Joshi
Journal:  Cancer Chemother Pharmacol       Date:  2016-01-25       Impact factor: 3.333

10.  Relationship between factor VIII activity, bleeds and individual characteristics in severe hemophilia A patients.

Authors:  João A Abrantes; Alexander Solms; Dirk Garmann; Elisabet I Nielsen; Siv Jönsson; Mats O Karlsson
Journal:  Haematologica       Date:  2019-08-01       Impact factor: 9.941
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.